Company Profile

AARTI DRUGS LTD.

NSE : AARTIDRUGSBSE : 524348ISIN CODE : INE767A01016Industry : Pharmaceuticals & DrugsHouse : Aarti
BSE667.652.6 (+0.39 % )
PREV CLOSE (Rs.) 665.05
OPEN PRICE (Rs.) 668.00
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 56415
TODAY'S LOW / HIGH (Rs.)662.30 670.00
52 WK LOW / HIGH (Rs.)427.5 1025
NSE667.40 2.5 (+0.38 % )
PREV CLOSE(Rs.) 664.90
OPEN PRICE (Rs.) 669.80
BID PRICE (QTY) 667.40 (181 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 285665
TODAY'S LOW / HIGH(Rs.) 662.75 670.20
52 WK LOW / HIGH (Rs.)425.25 1026.95

Smart Quotes

1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Trade Value (Rs. in Lacs) 0.00
Dividend Yield(%) 0.30
TTM EPS (Rs.) 24.86
P/E Ratio 26.85
Book Value (Rs.) 91.27
Face Value (Rs.) 10
MCap (Rs. in Mn) 61824.39
Price/Earning (TTM) 22.27
Price/Sales (TTM) 3.18
Price/Book (MRQ) 7.32
PAT Margin (%) 8.30
ROCE (%) 21.29
Incorporation Year : 1984

Management Info :

Prakash M Patil - Chairman Rashesh C Gogri - Managing Director

Registered Office :

Address : Plot No N 198,M I D C,Tarapur Village - Patembhi, Taluka Palghar,
Thane,
Maharashtra-401506

Phone :

Email : NA

Website : www.aartidrugs.com

Registrar's Details : Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE
NEWS More
28Jul07-28-2021$Aarti Drugs informs about press release Aarti Drugs informs about pr
Aarti Drugs has informed that it enclosed press release on the Financial Results for the quarter ended June 30, 2021.

The above information is a part of company’s filings submitted to BSE.

Aarti Drugs has informed that it enclosed press release on the..
23Jul07-23-2021$Aarti Drugs informs about conference call Aarti Drugs informs about co

Aarti Drugs has informed that Conference Call for the Investors and Analysts has been scheduled on Wednesday, July 28, 2021 at 3:30 PM IST to discuss the Company's financial performance for the Quarter ended June 30, 2021. The company attached invitation for the same.

The above information is a part of company’s filings submitted to BSE.

Aarti Drugs has informed that Conference Call for the Investors..
22Jul07-22-2021$ Board Meeting Intimation for Board Meeting Board Meeting Intimation fo
AARTI DRUGS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/07/2021 ,inter alia, to consider and approve This is to inform you that next Meeting of the Board of Directors of the Company is scheduled to be held on Tuesday, July 27, 2021 to consider, approve and take on record Audited Financial Results for the Quarter ended June 30, 2021.
AARTI DRUGS LTD.has informed BSE that the meeting of the Board..
21Jul07-21-2021$Aarti Drugs informs about board meeting Aarti Drugs informs about bo
Aarti Drugs has informed that next Meeting of the Board of Directors of the Company is scheduled to be held on Tuesday, July 27, 2021 to consider, approve and take on record Audited Financial Results for the Quarter ended June 30, 2021.

The above information is a part of company’s filings submitted to BSE.

Aarti Drugs has informed that next Meeting of the Board of Dire..
28Jun06-28-2021$Aarti Drugs informs about annual secretarial compliance report Aarti Drugs informs about an

Aarti Drugs has informed that it has enclosed the Annual Secretarial Compliance Report of the Company issued by Sunil M. Dedhia & Co., Company Secretaries in Practice, for the financial year ended March 31, 2021.

The above information is a part of company’s filings submitted to BSE.

Aarti Drugs has informed that it has enclosed the Annual Secret..
Financials More
Rs. in Millions
QTR Jun 21 ANNUAL 21
Net Profit455.42577
Gross Profit 600.4 3377
Operating Profit 759.14076.9
Net Sales 5057.919148.9
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group More
Abbott India (BSE)
 19086.15 (4.92%)
M.Cap ( in Cr)
40556.74
Sanofi India (BSE)
 8367.90 (3.43%)
M.Cap ( in Cr)
19271.79
Alkem Laboratories (BSE)
 3454.55 (3.70%)
M.Cap ( in Cr)
41304.33
Sun Pharma Inds. (BSE)
 774.00 (10.06%)
M.Cap ( in Cr)
185708.53
Divi's Lab (BSE)
 4904.65 (1.20%)
M.Cap ( in Cr)
130203.05
Shareholding Pattern More
PROMOTERS 60.14 %
NON-INSTITUTION 35.29 %
MUTUAL FUNDS/UTI 1.85 %
FI/BANKS/INSURANCE 0.12 %
GOVERNMENT 0 %
FII 0 %
F & O Quotes